SANGRIX INC. Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount
SANGRIX INC. (BTOG) reported Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount of $2.39 million for the 12-month period ending 2024-06-30, per its 20-F filed 2026-09-18.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount · last filed 2026-09-18
| Period end | Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount 6 month | Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount 12 month | Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount 12 month as first filed |
|---|---|---|---|
| 2024-06-30 | $2.39M 20-F · filed 2026-09-18 | ||
| 2023-12-31 | $0.00 6-K · filed 2024-04-26 | ||
| 2023-06-30 | $610.30K 20-F · filed 2025-10-31 | ||
| 2022-12-31 | $0.00 6-K · filed 2024-04-26 | ||
| 2022-06-30 | $610.30K 20-F · filed 2025-10-31 | $0.00 20-F · filed 2023-10-31 | |
| 2021-06-30 | $0.00 20-F · filed 2023-10-31 |